Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-02-02

FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for aliskiren hemifumarate from Prasco Laboratories, making a generic version of aliskiren available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren (Aliskiren)

Snippet

SUPPL AP for ALISKIREN (ALISKIREN HEMIFUMARATE)